https://orcid.org/0000-0002-1777-9001
Citations (13)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (6)
Giulia Coscarella, Dalma Malvaso, Maria Mannino, Giacomo Caldarola, Barbara Fossati, Clara De Simone, Andrea Chiricozzi & Ketty Peris. (2023) The preclinical discovery and development of deucravacitinib for the treatment of psoriasis. Expert Opinion on Drug Discovery 18:11, pages 1201-1208.
Read now
Read now
Lluís Rusiñol, Elena Carmona-Rocha & Lluís Puig. (2023) Psoriasis: a focus on upcoming oral formulations. Expert Opinion on Investigational Drugs 32:7, pages 583-600.
Read now
Read now
Flavia Sunzini, Arianna D’Antonio, Mauro Fatica, Paola Triggianese, Paola Conigliaro, Elisabetta Greco, Alberto Bergamini & Maria Sole Chimenti. (2022) What’s new and what’s next for biological and targeted synthetic treatments in psoriatic arthritis?. Expert Opinion on Biological Therapy 22:12, pages 1545-1559.
Read now
Read now
Alan Vu, Caden Ulschmid & Kenneth B. Gordon. (2022) Anti-IL 23 biologics for the treatment of plaque psoriasis. Expert Opinion on Biological Therapy 22:12, pages 1489-1502.
Read now
Read now
Rohan Singh, Alexandria M Brown, Warren H Chan, Morgan A Farr, Sid Venkataraman & Steven R Feldman. (2022) Psoriatic arthritis improved on risankizumab: does the presence of psoriatic arthritis mean a drug approved for psoriatic arthritis has to be prescribed?. Expert Opinion on Biological Therapy 22:12, pages 1439-1441.
Read now
Read now
Sindhuja Koppu, Rohan Singh, Kiranjit Kaur & Steven R. Feldman. (2022) Review of bimekizumab in the treatment of psoriasis. Human Vaccines & Immunotherapeutics 18:6.
Read now
Read now
Articles from other publishers (7)
E. V. Svechnikova, S. E. Zhufina & M. A. Morzhanaeva. (2023) Clinical case: switching from basic therapy with methotrexate to therapy with netakimab, an IL-17 inhibitor, in a patient with severe psoriasis. Meditsinskiy sovet = Medical Council:2, pages 69-74.
Crossref
Crossref
Annegrit Decker, Franziska Schauer, Adhara Lazaro, Carmen Monasterio, Arthur Robert Schmidt, Annette Schmitt-Graeff & Wolfgang Kreisel. (2022) Esophageal lichen planus: Current knowledge, challenges and future perspectives. World Journal of Gastroenterology 28:41, pages 5893-5909.
Crossref
Crossref
Yu Pan, Dan Du, Lian Wang, Xiaoyun Wang, Gu He & Xian Jiang. (2022) The Role of T Helper 22 Cells in Dermatological Disorders. Frontiers in Immunology 13.
Crossref
Crossref
Hideyuki Ujiie, David Rosmarin, Michael P. Schön, Sonja Ständer, Katharina Boch, Martin Metz, Marcus Maurer, Diamant Thaci, Enno Schmidt, Connor Cole, Kyle T. Amber, Dario Didona, Michael Hertl, Andreas Recke, Hanna Graßhoff, Alexander Hackel, Anja Schumann, Gabriela Riemekasten, Katja Bieber, Gant Sprow, Joshua Dan, Detlef Zillikens, Tanya Sezin, Angela M. Christiano, Kerstin Wolk, Robert Sabat, Khalaf Kridin, Victoria P. Werth & Ralf J. Ludwig. (2022) Unmet Medical Needs in Chronic, Non-communicable Inflammatory Skin Diseases. Frontiers in Medicine 9.
Crossref
Crossref
S.P. Déo-Gracias Berry, Camille Dossou, Ali Kashif, Niusha Sharifinejad, Gholamreza Azizi, Haleh Hamedifar, Araz Sabzvari & Zeineb Zian. (2022) The role of IL-17 and anti-IL-17 agents in the immunopathogenesis and management of autoimmune and inflammatory diseases. International Immunopharmacology 102, pages 108402.
Crossref
Crossref
Eirini Tsirvouli, Felicity Ashcroft, Berit Johansen & Martin Kuiper. (2021) Logical and experimental modeling of cytokine and eicosanoid signaling in psoriatic keratinocytes. iScience 24:12, pages 103451.
Crossref
Crossref
Rohan Singh, Sindhuja Koppu, Patrick O. Perche & Steven R. Feldman. (2021) The Cytokine Mediated Molecular Pathophysiology of Psoriasis and Its Clinical Implications. International Journal of Molecular Sciences 22:23, pages 12793.
Crossref
Crossref